Celltrion
068270.KS
#815
Rank
NZ$53.62 B
Marketcap
NZ$233.83
Share price
-0.31%
Change (1 day)
14.26%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): NZ$4.37

According to Celltrion 's latest financial reports the company's current EPS (TTM) is NZ$4.27. In 2025 the company made an earnings per share (EPS) of NZ$5.23 an increase over its 2024 EPS that were of NZ$1.98.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$4.37-16.46%
2025NZ$5.23163.66%
2024NZ$1.98-53.73%
2023NZ$4.28-2.08%
2022NZ$4.38-11.72%
2021NZ$4.962.03%
2020NZ$4.8682.8%
2019NZ$2.6618.31%
2018NZ$2.25-36.33%
2017NZ$3.53161.25%
2016NZ$1.352.86%
2015NZ$1.3117.84%
2014NZ$1.115.87%
2013NZ$1.05-70.85%
2012NZ$3.61134.09%
2011NZ$1.5443.59%
2010NZ$1.0774.49%
2009NZ$0.62317.8%
2008NZ$0.15-71.7%
2007NZ$0.52